Power cut: inhibiting mitochondrial translation to target leukemia
- PMID: 22094249
- DOI: 10.1016/j.ccr.2011.10.028
Power cut: inhibiting mitochondrial translation to target leukemia
Abstract
In this issue of Cancer Cell, Skrtic et al. demonstrate that inhibition of mitochondrial ribosomes with tigecycline, a known antimicrobial, selectively kills leukemia cells. This finding highlights the metabolic susceptibility of leukemia cells to mitochondrial translational inhibition and identifies a compound with significant efficacy in an in vivo preclinical model.
2011 Elsevier Inc. All rights reserved.
Comment on
-
Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia.Cancer Cell. 2011 Nov 15;20(5):674-88. doi: 10.1016/j.ccr.2011.10.015. Cancer Cell. 2011. PMID: 22094260 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources